The Education Department used today’s issue to finalize the biggest rewrite of college accreditation rules in years, loosening who can become an accreditor and where a school can go shopping for one, while the White House revised the Canada tariff list for the fourth time since the summer and the DEA fast-tracked a newly approved ADHD drug into Schedule III. The issue runs 426 pages and carries 119 documents.
- Education Department — Accreditation, Innovation, and Modernization (final rule). The Department finalized a rewrite of the rules governing how it recognizes college accrediting agencies, which matters because accreditation is the gate a school must pass through before its students can receive federal financial aid. The rule drops the old “two-year rule” that made new accrediting agencies wait before they could win recognition, and it removes geographic restrictions that tied a school to an accreditor in its own region, so a college can now shop nationally for whichever recognized accreditor it prefers. Several commenters argued that the rule’s 30-day comment period and nine-day negotiated rulemaking session were too short for a change of this scope, something the Department acknowledged and then rejected outright rather than extending. Read the rule.
- Executive Office of the President — Proclamation 11076, Canada tariff modification. This is the fourth proclamation since July in an ongoing dispute over Canadian motor-vehicle tariffs, and it moves one set of Canadian products off a 50 percent additional duty while adding a different set to it, effective for goods entered for consumption after midnight on October 30. Because this is done by presidential proclamation rather than through the normal trade-remedy process, the product list can be rewritten repeatedly with no public comment period or hearing, and this is the second such rewrite in two months alone. Read the proclamation.
- Centers for Medicare & Medicaid Services — CY 2027 ESRD Prospective Payment System (final rule). This 122-page rule, tucked into its own Part III of the issue, sets what Medicare will pay dialysis providers in 2027, adjusts a separate payment track for dialysis tied to acute kidney injury, and revises the quality metrics that determine part of each facility’s payment. It is easy to overlook next to the day’s higher-profile items, but it is the rule that resets, every year without much public notice, how a multibillion-dollar slice of Medicare spending reaches the roughly 7,000 dialysis facilities nationwide. Read the rule.
- Drug Enforcement Administration — centanafadine placed in Schedule III (interim final rule). The DEA used a newer, faster legal track, created by a 2023 law for drugs that combine FDA approval with stimulant-like effects, to place this new ADHD medication into Schedule III effective the same day it was published. That track lets the rule take effect immediately and only afterward opens a comment period, which runs through November 30, rather than collecting public input before the rule binds doctors and pharmacies. Schedule III status means the drug can still be prescribed but under tighter recordkeeping and refill limits than an unscheduled medication, and DEA’s own data show it found less abuse potential here than in the stimulants already in Schedule II. Read the rule.
- Homeland Security Department / CISA — order excluding Acronis products from federal civilian IT systems. Citing the Federal Acquisition Supply Chain Security Act, the Secretary ordered Acronis-branded products barred from federal civilian procurement and removed from systems where they are already installed, after a recommendation from the Federal Acquisition Security Council. The notice names the company but does not describe the underlying security evidence, which is filed separately in a non-public docket, so the public record here states the outcome without showing the reasoning behind it. A government-wide procurement ban is a rare and serious step for a single vendor, since it effectively closes off that company’s access to the entire civilian federal market. Read the notice.
- CDC — amended attestation order for travelers connected to the Democratic Republic of the Congo. The amended order requires anyone boarding a U.S.-bound flight to sign an attestation that they have not been in the DRC within the prior 21 days, unless they qualify for an exemption, and it is set to run through December 18 unless CDC changes it sooner. Travel-specific entry conditions like this one are usually tied to an active disease-outbreak concern rather than a broad travel ban, and the detail worth watching is whether the list of covered countries or the attestation requirement expands as the situation develops. Read the notice.
Editorial note: We reviewed all 119 documents published in today’s Federal Register before selecting these six. Excluded as routine: sixteen National Park Service inventory-completion and repatriation notices, Foreign-Trade Zone production-activity notices, Securities and Exchange Commission self-regulatory-organization filings, antidumping and countervailing-duty administrative review and sunset-review results, Coast Guard safety-zone rules, FERC licensing and combined-filing notices, routine Paperwork Reduction Act information-collection notices, and standard meeting and hearing announcements.
